Fig. 1From: A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinibDetection of a somatic KRAS mutation (c.35G > T; p.G12V) in DNA extracted from micro-dissected tumor cells from the patient with recurrent low-grade serous carcinoma. DNA extracted from micro-dissected adjacent stromal cells was used as normal control. Sequencing chromatograms were generated using PCR Sanger sequencing with AB3730XL sequencerBack to article page